CytoDyn (CYDY) Preferred Shares (2011 - 2020)

CytoDyn's Preferred Shares history runs 10 years deep, the most recent figure standing at $92.0 for Q2 2020.

• Quarterly Preferred Shares changed 0.0% year-over-year to $92.0 in Q2 2020, while the trailing twelve-month figure through May 2020 was $92.0 (changed 0.0% YoY) and the FY2020 annual result came in at $92.0, changed 0.0% from the prior year.
• Preferred Shares was $92.0 for Q2 2020 at CytoDyn, up from $8.0 in the prior quarter.
• Across five years, Preferred Shares topped out at $95.0 in Q1 2016 and bottomed at $5.0 in Q3 2019.
• A 5-year average of $77.71 and a median of $92.0 in 2017 frame the typical range for Preferred Shares.
• Peak annual rise in Preferred Shares reached 0.0% in 2016, while the deepest fall reached 99.96% in 2016.
• CytoDyn's Preferred Shares stood at $95.0 in 2016, then retreated by 3.16% to $92.0 in 2017, then changed by 0.0% to $92.0 in 2018, then plunged by 91.3% to $8.0 in 2019, then jumped by 1050.0% to $92.0 in 2020.
• Business Quant data shows CYDY's Preferred Shares at $92.0 in Q2 2020, $8.0 in Q1 2020, and $8.0 in Q4 2019.